St. Jude Medical Inc. (STJ) said that it has received the FDA clearance for its Swift-Lock anchor, a new product designed to help physicians efficiently secure neurostimulation leads utilized in spinal cord stimulation therapy for the management of chronic pain.
The company noted that the Swift-Lock anchor eliminates the need for sutures or medical adhesive typically required to secure the anchor to the lead. Featuring an easy-to-use mechanical lock, physicians secure the anchor with a simple 90-degree twist. This design minimizes the complexity and variability associated with anchoring leads.
St. Jude Medical said it is developing new technologies to address a growing list of neurological disorders. Clinical studies are currently underway for Parkinson's disease, essential tremor, migraine headaches, major depressive disorder, and others.
For comments and feedback contact: editorial@rttnews.com
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.